Here are five predictions:
1. The market will grow at a 4.4 percent compound annual growth rate between 2016 and 2023.
2. An increasing geriatric population; growing number of fracture, osteoporosis and spinal diseases cases; and an increasing patient awareness of stimulation treatments will spur the market.
3. China will lead the region’s market, growing at a 6.1 percent CAGR through 2023.
4. China’s market only encapsulates external bone growth simulators, as the country has not approved implantable devices.
5. The Chinese market favors domestically manufactured devices by offering high reimbursement rates.
More articles on devices:
Medtronic, Exactech, RTI Surgical & more: 9 device company key notes
AxioMed president comments on outpatient cervical disc replacement study: 5 observations
North America leads global neurosurgery market — 5 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
